We describe the use of 11CRTI-55 and the Multiple Objects Coincidences Counter (MOCC) to detect in-vivo binding to peripheral serotonin reuptake sites (left chest comprising platelet and lung serotonin reuptake sites) in man. Displacement and preloading experiments with clomipramine and venlafaxine in two healthy volunteers demonstrated that 11CRTI-55 binding is decreased in a dose-dependent fashion by both these drugs which bind to the serotonin transporter. In addition parallel data from the total head curve (representing 11CRTI-55 binding to central serotonin and dopamine (DA) reuptake sites) suggest that prior blockade of the serotonin transporter may be a useful strategy to maximize radioactive counts in the head when measuring the DA transporter. The MOCC is likely to be useful to determine sequential indices of relative serotonin reuptake blockade in patients on treatment.
Boja J.W., Mitchell W.M., Patel A., Kopajtic TA, Carroll F.I., Lewin A.H., Abraham P., Kuhar MJ (1992) High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse12: 27-36
Brown D.J., Luthra S.K., Brown G.D., Carroll F.I., Kuhar M.J., Osman S., Waters S.L., Brady F. (1994) [11C]RTI—121—A potential radioligand for PET studies of the dopamine transporter. J Label Comp Radiopharm35: 483-484
4.
Carroll F.I., Kotian P., Dehghani A., Gray J.L., Kuzemko M.A., Parnham K.A., Abraham P., Lewin A.H., Boja J.W., Kuhar M.J. (1995) Cocaine and 3β- (4'-substituted phenyl) tropane 2β carboxylic acid ester and amide analogues. New high affinity and selective compounds for the dopamine transporter. J Med Chem38:379-388
5.
Evans J., Battersby S., Ogilvie A.D., Smith C A D, Harmar A.J., Nutt D.J., Goodwin G.M. (1997) Association of short alleles of a VNTR of the serotonin transporter gene with anxiety symptoms in patients presenting after deliberate self-harm. Neuropharmacology, in press
6.
Farde L., Halldin C., Muller L., Suhara T., Karlsson P., Hall H. ( 1994) PET study of [11C]beta CIT binding to monoamine transporters in the monkey and human brain. Synapse16: 93-103
7.
Fozard J (ed.) (1989) Peripheral actions of 5-hydroxytryptamine. Oxford University Press , New York
8.
Jones A K P, Cunningham VJ, Ha-Kawa S.K., Fujiwara T., Liyii Q., Luthra S.K., Ashburner J., Osman S., Jones T. (1994) Quantitation of [11C]diprenorphine cerebral kinetics in man acquired by PET using presaturation, pulse-chase and tracer only protocols . J Neurosci Meth51: 123-134
9.
Kuikka J.T., Tiihonen J., Bergstrom K.A., Karhu J., Hartikainen P., Viinmaki H., Lansimies E., Lehtonen J., Hakola P. (1995) Imaging of serotonin and dopamine transporters in the living human brain. Eur J Nucl Med22: 346-350
10.
Laruelle M., Baldwin R.M., Malison R.T., Zea-Ponce Y., Zoghbi S.S., al Tikriti M.S., Sybirska E.H., Zimmermann R.C., Wisniewski G., Neumeyer J.L. (1993) SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse13: 295-309
11.
Malizia A.L., Forse G., Haida A., Gunn R., Melichar J., Poole, K., Bateman B., Fahy D., Schnorr L., Brown D., Rhodes C., Nutt D.J., Jones T. (1995) A new human (psycho)pharmacology tool: the multiple organs coincidences counter (MOCC). J Psychopharmac9: 294-306
12.
Malizia A.L., Forse G., Gunn R.N., Haida A., Schnorr L., Rajeswaran S., Poole K., Nutt D., Jones T. (1996) The MOC counter: a pharmacological tool for the in vivo measurement of ligand occupancy indices in the human brain. In Myers R, Cunningham V, Bailey D, Jones T, (eds), Quantification of brain function using PET . Academic Press, London, pp. 20-25
13.
Ogilvie A.D., Battersby S., Bubb VJ, Fink G., Harmar A.J., Goodwim GM, Smith CA (1996) Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet347:731-733
14.
Scheffel U., Dannals RF, Cline EJ, Ricaurte GA, Carroll FI, Abraham P., Lewin A.H., Kuhar M.J. (1992) [123/125I]RTI-55, an in vivo label for the serotonin transporter. Synapse11: 134-139
15.
Scheffel U., Kim S., Cline E.J., Kuhar M.J. (1994) Occupancy of the serotonin transporter by fluoxetine, paroxetine, and sertraline: in vivo studies with [125I]RTI-55. Synapse16: 263-268
16.
Wagner A., Montero B., Martensson B., Siuuers B., Asberg M. (1990) Effects of fluoxetine treatment on platelet 3[H]Imipramine binding, 5HT uptake and 5HT content in Major Depressive Disorder. J Affect Disorders20:110-113
